SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $133,842 | +6.1% | 5,789 | +20.3% | 0.01% | 0.0% |
Q2 2023 | $126,171 | +86.1% | 4,812 | +82.7% | 0.01% | +66.7% |
Q1 2023 | $67,799 | -6.6% | 2,634 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $72,567 | -3.2% | 2,634 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $75,000 | +17.2% | 2,634 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $64,000 | -50.4% | 2,634 | +15.1% | 0.00% | -40.0% |
Q1 2022 | $129,000 | -9.2% | 2,289 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $142,000 | -2.1% | 2,289 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $145,000 | -23.3% | 2,289 | 0.0% | 0.01% | -28.6% |
Q2 2021 | $189,000 | +27.7% | 2,289 | +13.7% | 0.01% | +16.7% |
Q1 2021 | $148,000 | +1.4% | 2,013 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $146,000 | +64.0% | 2,013 | +7.5% | 0.01% | +75.0% |
Q3 2020 | $89,000 | +12.7% | 1,872 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $79,000 | +229.2% | 1,872 | +108.7% | 0.00% | +300.0% |
Q1 2020 | $24,000 | -31.4% | 897 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $35,000 | – | 897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |